Ac-225-PSMA-617 for PSMA targeting alpha-radiation therapy of 28 patients with mCRPC

KRATOCHWIL, Clemens; BRUCHERTSEIFER, Frank; GIESEL, Frederik; APOSTOLIDIS, Christos; HABERKORN, Uwe; MORGENSTERN, Alfred

doi:10.1007/s00259-016-3484-4

An official website of the European Union How do you know?

Ac-225-PSMA-617 for PSMA targeting alpha-radiation therapy of 28 patients with mCRPC

We evaluate imaging and tumor marker response as well as clinical and hematological toxicity of targeted alpha-radiation therapy with Ac-225-PSMA-617 (TAT) in inter-individual comparison to Lu-177-PSMA-617 in dependency of prognostic factors.

KRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; APOSTOLIDIS Christos; HABERKORN Uwe; MORGENSTERN Alfred;

2016-12-01

SPRINGER

JRC101406

1619-7070,

https://publications.jrc.ec.europa.eu/repository/handle/JRC101406,

10.1007/s00259-016-3484-4,

Name	Country	City	Type

Datasets

ID	Title	Public URL

Dataset collections

ID	Acronym	Title	Public URL

Scripts / source codes

Description	Public URL

Additional supporting files

File name	Description	File type

Show metadata record Copy citation url to clipboard Download BibTeX

Items published in the JRC Publications Repository are protected by copyright, with all rights reserved, unless otherwise indicated. Additional information: https://ec.europa.eu/info/legal-notice_en#copyright-notice